Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : PanAmerican BanCorp (PABN) -- Ignore unavailable to you. Want to Upgrade?

To: ROSARIO who wrote (22360)	1/7/1999 8:50:00 AM
From: Style Writer	Read Replies (1) \| Respond to of 43774

Another destructive piece of DD from the man who has no shares and no brains. Rosie, I personally hope that lots of people listen to your crap and sell. I will be waiting for all I can get at $.015. $.015 to $.50 in one year. Help me with the math Rosie, it looks like a mere 3333% return. Not as good as the 4000% I made from PRWT last year, but perfectly adequate for this gem of a penny stock. Go PRWT

To: ROSARIO who wrote (22360)	1/7/1999 9:52:00 AM
From: Big Bamboo	Respond to of 43774

ROSARIO, I am not sure if the crap I smell is coming from your mouth or just brewing in your skull. You try to make a negative out of everything that threatens you as a positive event. The retraction by NHLT has nothing to do with financing. Read it again but first, please wipe the crap from your eyes. WARMINSTER, Pa., Jan. 6 /PRNewswire/ -- National Health & Safety Corporation (OTC Bulletin Board: NHLT - news) announced today a clarification of one portion of the press release made earlier today by the company that it was in the final stages of negotiation for financing. Dr. Dennis Bowers, CEO of National Health & Safety, said that the press release included a statement that the Longport Digital Scanner technology for which National Health & Safety has obtained exclusive North American marketing rights ''can detect various forms of cancer without the need for invasive surgery.'' Bowers said that the wording regarding the Longport Digital Scanner was accidentally and prematurely released. A clinical trial is currently underway at Thomas Jefferson University Department of Radiology, Division of Ultrasound, Philadelphia, PA to study ''High Resolution Skin Ultrasound for Evaluating Patients with known Primary Melanoma for Satellite or intransit Metastases.'' Therefore, Bowers said, it has yet to be proven that the ''LDS'' can detect skin cancer cells. There are other areas of application currently being tested for the LDS technology including breast pathology. Bowers said that the responsibility for the error in wording in the first press release was totally the responsibility of National Health & Safety and did not result from information received from Longport, Inc. (OTC symbol ''LPTI'').